Increase in research and development expenditure will boost the growth of market during the forecast period 2023- 2030

Pune, India, February 28, 2022 /press release/- Market Research Future Published a Half Cooked Research Report on Global Autoimmune Disease Treatment Market

Autoimmune Disease Treatment Market Overview

An autoimmune disorder occurs when the body’s immune system is unable to differentiate between own cells and foreign cells, which causes the body to mistakenly attack normal cells. The most common autoimmune disease symptoms include abdominal pain, recurring fever, swollen glands, fatigue, and joint pain, swelling, and skin problems.

On the regional basis, the Americas autoimmune disease treatment market is segmented into two major regions North America and South America. The North American region holds a major share of the global autoimmune disease treatment market owing to the rising prevalence of autoimmune diseases, existing well-established healthcare system, and improving funding and reimbursement policies.

Autoimmune Disease Treatment Market Size is anticipated to reach USD 2.15 billion by 2030, at a CAGR of 6.90% during the forecast period (2023 - 2030). 

North America is furtexhibiting a compound annual growth rate her segmented into the United States and Canada. The United States holds the major share of the market owing to the well-developed economy and rising cases of rheumatoid arthritis. According to a study published in the Rheumatology International journal in 2017, it is found that the prevalence of rheumatoid arthritis in the U.S. ranged from 0.53 to 0.55%. According to the Centers for Disease Control and Prevention (CDC), in 2017, around 22.7% of adults had doctor-diagnosed arthritis with higher prevalence in women i.e. 23.5% than in men i.e. 18.1%.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Autoimmune Disease Treatment Market Research Report

Various other factors such as, increasing government assistance, rising prevalence of co-existing disorders, improving regulatory framework, increase in research and development expenditure, rising funding and reimbursement, and increasing adoption rate may contribute to the growth of the global connective tissue disease market.

South America is still a developing region in terms of the infrastructure and technology.

The global autoimmune disease treatment market is segmented on the basis of disease type, diagnosis, therapeutic products, and distribution channels.

Some of key the players in the global autoimmune disease treatment market are Abbott Laboratories, Amgen Inc., Genentech Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bio-Rad, Chugai Pharmaceutical Co. Ltd., Danaher, Elan Corporation Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, HYCOR Biomedical, Johnson & Johnson Inc., Merck & Co. Inc., Siemens, Squibb Company, Thermo Fisher Scientific, and others.